Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A for Cognitive and Functional Impairment in Schizophrenia
NCT00963846Phase 2Completed
- Start
- Mar 2010
- Primary completion
- Dec 2012
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huperzine A in schizophrenia. Started Mar 2010; status: completed.
02
Drugs
Huperzine A
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00963846.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00963846.